FRESENIUS MEDICAL CARE AG/ DE0005785802 /
12/3/2024 5:29:46 PM | Chg. +1.21 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
44.33EUR | +2.81% | 258 Turnover: 1.39 mill. |
-Bid Size: - | -Ask Size: - | 13.04 bill.EUR | 2.68% | 26.14 |
Assets
2017 - in mill. EUR |
2018 - in mill. EUR |
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 3,491.8000 | 3,836 | 4,190.3000 | 4,056.9000 | 4,235 | ||||||
Intangible Assets | 683.1000 | 681.3000 | 1,426.3000 | 1,381 | 1,459.4000 | ||||||
Long-Term Investments | 647 | 649.8000 | 696.9000 | 761.1000 | 786.9000 | ||||||
Fixed Assets | - | - | - | - | - | ||||||
Inventories | 1,290.8000 | 1,466.8000 | 1,663.3000 | 1,895.3000 | 2,038 | ||||||
Accounts Receivable | 3,331 | 3,337.7000 | 3,421.3000 | 3,153 | 3,409.1000 | ||||||
Cash and Cash Equivalents | 978.1000 | 2,145.6000 | 1,007.7000 | 1,081.5000 | 1,481.7000 | ||||||
Current Assets | 6,374.3000 | 7,846.9000 | 7,165.1000 | 7,275.3000 | 7,967.2000 | ||||||
Total Assets | 24,025.1000 | 26,242.3000 | 32,934.7000 | 31,689 | 34,366.6000 |
Liabilities
2017 - in mill. EUR |
2018 - in mill. EUR |
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 590.5000 | 641.3000 | 716.5000 | 732 | 736.1000 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | 760.3000 | 1,205.3000 | 1,150 | 63 | 1,178.4000 | ||||||
Provisions | 467.5000 | 626.5000 | 739.7000 | 785.9000 | 868.5000 | ||||||
Liabilities | 14,205 | 14,483.9000 | 19,707.5000 | 19,357.7000 | 20,387.5000 | ||||||
Share Capital | 308.1000 | 307.8790 | 304.4370 | 292.8770 | 293.0040 | ||||||
Total Equity | 9,820.1000 | 11,758.4000 | 11,957.9000 | 11,215.1000 | 12,698.8000 | ||||||
Minority Interests | - | - | 1,269.3000 | 1,116.2000 | 1,280.3000 | ||||||
Total liabilities equity | 24,025.1000 | 26,242.3000 | 32,934.7000 | 31,689 | 34,366.6000 |
Income Statement
2017 - in mill. EUR |
2018 - in mill. EUR |
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 17,783.6000 | 16,546.9000 | 17,476.6000 | 17,859.1000 | 17,618.7000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 2,362.4000 | 3,037.8000 | 2,269.6000 | 2,304.4000 | 1,852.3000 | ||||||
Interest Income | -353.9000 | -301.1000 | -429.5000 | -368 | -280.4000 | ||||||
Income Before Taxes | 2,008.5000 | 2,736.7000 | 1,840.1000 | 1,936.4000 | 1,571.9000 | ||||||
Income Taxes | 454 | 511.1000 | 401.6000 | 500.6000 | 352.8000 | ||||||
Minority Interests Profit | -274.7000 | -243.7000 | -238.9000 | -271.5000 | -249.7000 | ||||||
Net Income | 1,279.8000 | 1,981.9000 | 1,199.6000 | 1,164.4000 | 969.3000 |
Per Share
Cash Flow
2017 - in mill. EUR |
2018 - in mill. EUR |
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 2,191.8000 | 2,061.9000 | 2,567 | 4,233.2000 | 2,489.5000 | ||||||
Cash Flow from Investing Activities | -991.5000 | -245 | -3,286 | -1,334.9000 | -1,196.2000 | ||||||
Cash Flow from Financing | -798.6000 | -681.7000 | -466.6000 | -2,664 | -1,024.4000 | ||||||
Decrease / Increase in Cash | 282.1000 | 1,167.5000 | -1,137.9000 | 73.8000 | 400.1000 | ||||||
Employees | 114,000 | 112,658 | 120,659 | 125,364 | 122,909 |